Recursion Pharmaceuticals, Inc. RXRX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s other income (expense)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported other income (expense) of $6.4M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s other income (expense) increased by 156.7% year-over-year, from -$11.28M to $6.4M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s other income (expense) has grown at a -3.5% compound annual growth rate (CAGR), from -$3.73M to $3.24M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.